Baird Financial Group Inc. Raises Position in Philip Morris International Inc. $PM

Key Points

• Baird Financial Group increased its Philip Morris stake by 7.1% in the second quarter, acquiring 18,790 additional shares for a total holding valued at approximately $51.5 million. Institutional investors collectively own 78.63% of PM’s shares.
• Analysts remain broadly bullish, with 10 Buy ratings and two Holds. The consensus rating is “Moderate Buy,” with an average price target of $205.89; several brokerages recently raised their targets to between $215 and $225.
• Philip Morris beat quarterly expectations, reporting $2.20 EPS and $11.19 billion in revenue, up 10.4% year over year. Growth initiatives include expanded ZYN nicotine-pouch offerings and FDA authorization for 11 ZYN products, though execution and consumer adoption remain important risks.

Baird Financial Group Inc. grew its holdings in Philip Morris International Inc. (NYSE:PM - Free Report) by 7.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 284,702 shares of the company's stock after acquiring an additional 18,790 shares during the period. Baird Financial Group Inc.'s holdings in Philip Morris International were worth $51,505,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of PM. Brighton Jones LLC boosted its stake in shares of Philip Morris International by 31.1% in the 4th quarter. Brighton Jones LLC now owns 8,531 shares of the company's stock valued at $1,027,000 after buying an additional 2,023 shares during the period. Revolve Wealth Partners LLC increased its stake in shares of Philip Morris International by 4.5% during the fourth quarter. Revolve Wealth Partners LLC now owns 2,097 shares of the company's stock worth $252,000 after buying an additional 91 shares during the period. Sivia Capital Partners LLC increased its stake in shares of Philip Morris International by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 5,636 shares of the company's stock worth $1,027,000 after buying an additional 1,970 shares during the period. Jump Financial LLC acquired a new stake in Philip Morris International in the second quarter valued at approximately $2,454,000. Finally, Osterweis Capital Management Inc. raised its holdings in Philip Morris International by 2,280.0% in the second quarter. Osterweis Capital Management Inc. now owns 357 shares of the company's stock valued at $65,000 after acquiring an additional 342 shares in the last quarter. Hedge funds and other institutional investors own 78.63% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PM. Weiss Ratings reiterated a "buy (b)" rating on shares of Philip Morris International in a research note on Monday, August 17th. Needham & Company LLC increased their price objective on shares of Philip Morris International from $200.00 to $215.00 and gave the company a "buy" rating in a research report on Thursday, July 23rd. Citigroup raised their price objective on shares of Philip Morris International from $210.00 to $225.00 and gave the company a "buy" rating in a report on Thursday, July 30th. BTIG Research set a $221.00 price objective on shares of Philip Morris International and gave the stock a "buy" rating in a research report on Friday, July 24th. Finally, Barclays boosted their target price on shares of Philip Morris International from $205.00 to $225.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 29th. Ten research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $205.89.

Philip Morris International Trading Up 0.5%

PM stock opened at $185.71 on Thursday. The stock has a market cap of $289.45 billion, a P/E ratio of 26.68, a PEG ratio of 2.37 and a beta of 0.37. Philip Morris International Inc. has a twelve month low of $142.11 and a twelve month high of $207.76. The company's 50 day moving average is $188.25 and its two-hundred day moving average is $178.77.

Philip Morris International (NYSE:PM - Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.05 by $0.15. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The business had revenue of $11.19 billion during the quarter, compared to analysts' expectations of $10.60 billion. During the same quarter in the prior year, the business posted $1.89 EPS. The company's revenue for the quarter was up 10.4% on a year-over-year basis. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities research analysts predict that Philip Morris International Inc. will post 8.39 earnings per share for the current year.

Key Stories Impacting Philip Morris International

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: Higher 2026 earnings outlook: Philip Morris raised its 2026 adjusted diluted EPS forecast to $8.35-$8.50, with the increase attributed to currency tailwinds rather than a change to its underlying operational outlook. The guidance supports investor confidence and is above the company’s previous expectations. Philip Morris Raises 2026 Earnings Guidance Amid Currency Tailwinds
• Positive Sentiment: ZYN portfolio expansion: PMI’s U.S. business is broadening ZYN with new 1.5 mg and 8 mg strengths, the higher-moisture ZYN ULTRA line, additional flavors and formats, and more pouches per can. The expanded range could attract more legal-age adult nicotine consumers and support volume growth. PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices
• Positive Sentiment: Regulatory support for nicotine pouches: FDA authorization for 11 ZYN products, including higher-strength ZYN ULTRA offerings, strengthens PMI’s position in the fast-growing U.S. nicotine-pouch market and provides a foundation for scaling production after substantial manufacturing investments. FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
• Neutral Sentiment: Execution remains important: The ZYN rollout is strategically favorable, but the earnings benefit will depend on consumer adoption, manufacturing capacity and the company’s ability to convert product expansion into sustainable sales and profit growth.

Philip Morris International Profile

Philip Morris International Inc is a global tobacco and nicotine company headquartered in Stamford, Connecticut. The company develops, manufactures and markets cigarettes, smoke-free products, nicotine products and related consumer offerings in markets around the world.

Its portfolio includes internationally recognized cigarette brands such as Marlboro, Parliament, L&M and Chesterfield. PMI is also expanding beyond traditional cigarettes through heated-tobacco products, including IQOS, e-vapor products such as VEEV, and oral nicotine products including ZYN, which became part of the company's portfolio following its acquisition of Swedish Match.

Philip Morris International was established as an independent company in 2008 after being separated from Altria Group, whose U.S.

Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.